行情

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ

实时行情|Nasdaq Last Sale

0.7887
-0.0128
-1.60%
已收盘, 16:00 01/29 EST
开盘
0.8100
昨收
0.8015
最高
0.8300
最低
0.7739
成交量
8,129
成交额
--
52周最高
2.720
52周最低
0.6700
市值
12.01万
市盈率(TTM)
-0.9689
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATHE 新闻

  • 中概股周三普遍下跌:乐居、1药网跌幅超10%
  • 新浪科技.34分钟前
  • 传秘密母公司CEO为其物色新买家 L Brands股价大涨12%
  • 新浪美股.53分钟前
  • 特斯拉Q4营收超预期 盘后涨逾7%股价破600美元关口
  • 新浪美股.55分钟前
  • 微软第二季度营收超预期 股价盘后涨超2%
  • 新浪美股.1小时前

更多

所属板块

生物技术和医学研究
-0.30%
制药与医学研究
+0.09%

热门股票

名称
价格
涨跌幅

ATHE 简况

Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
展开

Webull提供Alterity Therapeutics Ltd (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。